Fundz

Renalytix Announces A $30.0 Million Financing Package

PUBLIC · RNLXYMar 31, 2022

Round Type

Funding Round

New YorkBiotechnology

Description

Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces pricing of a $30.0 million financing package (the “Fundraise”).

Quick answer

Renalytix raised an undisclosed amount in a Funding Round round, dated March 31, 2022. Renalytix is based in New York, New York, United States.

How much did Renalytix raise?
Renalytix raised an undisclosed amount in a Funding Round round on March 31, 2022.
What does Renalytix do?
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
Where is Renalytix based and how big is it?
Renalytix is based in New York, New York, United States. Fundz records about 110 employees.
Who are the decision-makers at Renalytix?
Fundz holds 1 contact at Renalytix. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Renalytix that raised within 45 days of this round, from Fundz verified event records.

  • Rebalance Health, Inc. raised $7.6M on May 13, 2022.
  • NanoPhoria raised an undisclosed amount on May 12, 2022.
  • GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.
  • Impulse Dynamics raised $101M (Funding Round) on May 12, 2022.
  • DOSE Therapeutics, Inc. raised $10M on May 12, 2022.
  • BioAegis Therapeutics, Inc. raised $22M on May 11, 2022.

Who to call at Renalytix, and when

A new round usually means Renalytix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Renalytix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Renalytix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Renalytix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Renalytix

Location

New York, New York, United States

About

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Renalytix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Renalytix's next move

See what Strategic adds

Renalytix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.